Protein kinase inhibitors as sensitizing agents for chemotherapy /

Saved in:
Bibliographic Details
Imprint:London, United Kingdom : Academic Press, an imprint of Elsevier, [2019]
©2019
Description:1 online resource.
Language:English
Series:Cancer sensitizing agents for chemotherapy ; volume 4
Cancer sensitizing agents for chemotherapy ; v. 4.
Subject:Protein-tyrosine kinase -- Inhibitors -- Therapeutic use.
Cancer -- Chemotherapy.
Protein kinases -- Therapeutic use.
HEALTH & FITNESS / Diseases / General.
MEDICAL / Clinical Medicine.
MEDICAL / Diseases.
MEDICAL / Evidence-Based Medicine.
MEDICAL / Internal Medicine.
Cancer -- Chemotherapy.
Electronic books.
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11761090
Hidden Bibliographic Details
Other authors / contributors:Chen, Zhe-Sheng (Jason), editor.
Yang, Dong-Hua, editor.
ISBN:9780128127384
0128127384
9780128164358
0128164352
Notes:Includes bibliographical references and index.
Online resource; title from PDF title page (EBSCO, viewed November 27, 2018).
Summary:Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and BRAF. In each chapter, readers will find comprehensive knowledge on the inhibitor and its action, including its biochemical, genetic, and molecular mechanisms' emphases. This book is a valuable source for oncologists, cancer researchers and those interested in applying new sensitizing agents to their research in clinical practice and in trials.
Other form:Print version: 0128164352 9780128164358